Table of Contents PART 01: Executive summary PART 02: Scope of  the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Market segmentation by products Instruments and imaging systems Consumables and accessories PART 07: Market segmentation by application Breast cancer Lung cancer Colorectal cancer Lymphoma Cervical cancer Prostate cancer Other diseases PART 08: Market segmentation by end-user Hospitals Clinical diagnostic laboratories Physicians’ office laboratories PART 09: Geographical segmentation Anatomic pathology testing market in Americas Anatomic pathology testing market in EMEA Anatomic pathology testing market in APAC PART 10: Market drivers Growing prevalence of cancer in demographics Use of biomarkers for disease diagnosis and increasing efficiency Paradigm shift toward precision diagnosis through personalized medicine PART 11: Impact of drivers PART 12: Market challenges Insurance coverage and reimbursement issues Limitations of closed systems High initial investment and maintenance cost PART 13: Impact of drivers and challenges PART 14: Market trends Presence of venture capitalists in market Ready-to-use reagents Business strategies to increase market competitiveness PART 15: Vendor landscape Competitive landscape analysis PART 16: Key vendor analysis Abbott Diagnostics Agilent Technologies Danaher Roche Diagnostics Thermo Fisher Scientific Other prominent vendors PART 17: Appendix List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Methods used in anatomic pathology testing Exhibit 03: Use of digital pathology testing Exhibit 04: Global anatomic pathology testing market 2016-2021 ($ millions) Exhibit 05: Product dynamic analysis of instruments and reagents in 2016 and 2021 Exhibit 06: Five forces analysis Exhibit 07: Global anatomic pathology testing market by products in 2016 and 2021 ($ billions) Exhibit 08: Market overview: Instruments and imaging systems Exhibit 09: Anatomic pathology testing market by instruments and imaging systems 2016-2021 ($ billions) Exhibit 10: Market overview: Consumables and accessories Exhibit 11: Anatomic pathology testing market by consumables and accessories 2016-2021 ($millions) Exhibit 12: Global anatomic pathology testing market by application in 2016 Exhibit 13: Global anatomic pathology testing market by end-users in 2015 Exhibit 14: Strategies, benefits and challenges of clinical diagnostic laboratories to remain competitive Exhibit 15: Global anatomic pathology testing market by geography in 2016 and 2021 ($billions) Exhibit 16: Market overview: Anatomic pathology testing market in Americas Exhibit 17: Anatomic pathology testing market in Americas 2016-2021 ($ billions) Exhibit 18: Key takeaway: Anatomic pathology testing market in US Exhibit 19: PEST analysis: Anatomic pathology testing market in UK Exhibit 20: Market overview: Anatomic pathology testing market in EMEA Exhibit 21: Anatomic pathology testing market in EMEA 2016-2021 ($billions) Exhibit 22: Key takeaway: Anatomic pathology testing market in UK Exhibit 23: PEST analysis: Anatomic pathology testing market in UK Exhibit 24: Market overview: Anatomic pathology testing market in APAC Exhibit 25: Anatomic pathology testing market in APAC 2016-2021 ($billions) Exhibit 26: Key takeaway: Anatomic pathology testing market in China Exhibit 27: PEST analysis: Anatomic pathology testing market in China Exhibit 28: People in age group 60 years and above worldwide 2010-2050 Exhibit 29: Companies and laboratories focusing on biomarkers Exhibit 30: Companies focusing on companion diagnostic and personalized medicine Exhibit 31: Impact of drivers Exhibit 32: Impact of drivers and challenges Exhibit 33: Partnership between companies and venture capitalists Exhibit 34: Business strategies by companies to remain competitive in market Exhibit 35: Competitive structure analysis of global anatomic pathology testing market 2015 Exhibit 36: Competitive analysis of global anatomic pathology testing market 2016 Exhibit 37: Abbott Diagnostics: Strength assessment Exhibit 38: Abbott Diagnostics: Strategy assessment Exhibit 39: Abbott Diagnostics: Opportunity assessment Exhibit 40: Agilent Technologies: Strength assessment Exhibit 41: Agilent Technologies: Strategy assessment Exhibit 42: Agilent Technologies: Opportunity assessment Exhibit 43: Danaher: Strength assessment Exhibit 44: Danaher: Strategy assessment Exhibit 45: Danaher: Opportunity assessment Exhibit 46: Roche Diagnostics: Strength assessment Exhibit 47: Roche Diagnostics: Strategy assessment Exhibit 48: Roche Diagnostics: Opportunity assessment Exhibit 49: Thermo Fisher Scientific: Strength assessment Exhibit 50: Thermo Fisher Scientific: Strategy assessment Exhibit 51: Thermo Fisher Scientific: Opportunity assessment Exhibit 52: Other prominent vendors

Abbott Diagnostics, Agilent Technologies, Danaher, Roche Diagnostics, Thermo Fisher Scientific, 20/20 GeneSystems, Abcam, AdnaGen, Advanced Cell Diagnostics, Agendia, Angsana Molecular & Diagnostics Laboratory, AutoGenomics, Biocare Medical, Biocartis, CellMax Life, Cancer Genetics, Digipath, Enzo Biochem, Epic Sciences, Janssen Diagnostic, Monogram Biosciences, Nucleix, Omnyx, Oxford Cancer Biomarkers, RareCyte, SAKURA FINETEK USA, Tecan, VolitionRx.